---
layout: post
title: "N-MYC DOWNSTREAM-REGULATED GENE 2 (NDRG2): INOVASI PENANDA TUMOR DIAGNOSTIK DAN PROGNOSTIK TERBARU UNTUK KANKER PARU"
author: "Yulian Prastisia, Ghea Mangkuliguna, Nikolaus Tobian"
description: "Abstrak Latar Belakang Kanker paru menyebabkan kematian pada satu dari lima orang di dunia Tingginya angka mortalitas ini dikarenakan oleh belum adanya metode diagnosi"
categories: essential
canonical_url: https://jurnal.harianregional.com/essential/id-58646
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/essential/id-58646"
citation_pdf_url: "https://jurnal.harianregional.com/essential/full-58646"
tags:

---

## Authors:
Yulian Prastisia, Ghea Mangkuliguna, Nikolaus Tobian

## Abstract:
"Abstrak Latar Belakang: Kanker paru menyebabkan kematian pada satu dari lima orang di dunia. Tingginya angka mortalitas ini dikarenakan oleh belum adanya metode diagnosis yang dapat mendeteksi lesi dini kanker paru secara akurat. Akibatnya, banyak pasien yang baru terdiagnosis ketika kanker sudah mencapai stadium lanjut yang tingkat kelangsungan hidup tidak lebih dari 5%. Pada kondisi ini, terapi pembedahan sudah tidak dapat dilakukan dan terapi farmakologis pun kurang memberikan manfaat yang berarti. Baru-baru ini, ekspresi dari gen N-myc downstream-regulated 2 (NDRG2) ditemukan mengalami penurunan pada jaringan kanker paru yang menjadi dasar aplikasi NDRG2 sebagai penanda tumor diagnostik dan prognostik. Metode: Penelitian dilakukan dengan melakukan tinjauan pustaka dari beberapa database jurnal, yakni PubMed, ScienceDirect, dan Proquest dengan literatur yang dipublikasikan dalam kurun waktu 2009-2019. Pembahasan: Studi literatur ini menunjukkan bahwa sebanyak 56,7-64,5% dari pasien dengan kanker paru memiliki ekspresi NDRG2 yang sangat rendah. Ekspresi NDRG2 juga dikorelasikan dengan invasi tumor &amp; vaskular, ukuran, status diferensiasi, dan stadium tumor. Ekspresi NDRG2 yang rendah dapat menjadi indikator prognostik buruk bagi pasien kanker paru yang ditandai dengan penurunan tingkat kelangsungan hidup hingga 2 kali lipat lebih rendah. Simpulan: Dengan demikian, dapat disimpulkan bahwa NDRG2 memiliki potensi yang menjanjikan untuk menjadi penanda tumor diagnostik dan prognostik kanker paru."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- 1.	Centers for Disease Control and Prevention. What Is Lung Cancer ?. 2019 [Diakses 6 Desember 2019]. [Diambil dari: https://www.cdc.gov/cancer/lung/basic_info/what-is-lung-cancer.htm]
- 2.	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jernal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
- 3.	International Agency for Research on Cancer. GLOBOCAN 2018: estimated cancer incidence, mortality, and prevalence worldwide in 2018. 2019 [Diakses 6 Desember 2019] [Diambil dari: http://globocan.iarc.fr]
- 4.	Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
- 5.	Ofiara L, Navasakulpong A, Ezer N, Gonzalez A. The importance of a satisfactory biopsy for the diagnosis of lung cancer in the era of personalized treatment. Current Oncology. 2012;19: S16-23.
- 6.	Chen F, Li J, Qi X, Qi J. Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease. J Can Res Ther 2018;14, Suppl S2:400-4.
- 7.	Siegel RL, Miller KD and Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
- 8.	Rizvi NA, Peters S. Immunotherapy for unresectable stage iii non–small-cell lung cancer. New England Journal of Medicine. 2017; 377(20): 1986–1988.
- 9.	Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G and Walles T. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012:39;669–676.
- 10.	Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res. 2015;165(1):74–90.
- 11.	Tantai J, Pan X, Hu D. RNF4-mediated SUMOylation is essential for NDRG2 suppression of lung adenocarcinoma. Oncotarget. 2016;7(18).
- 12.	Wang H, Wang W, Wang X, Cai K, et al. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma. Med Oncol. 2012; 29(5):3162-3168.
- 13.	Li SJ, Wang WY, Li B, Chen B, et al. Expression of NDRG2 in human lung cancer and its correlation with prognosis. Med Oncol. 2013; 30(1):421.
- 14.	Hashimoto N, Sato M, Hasegawa Y. Pulmonary Malignancies (1): Lung Cancer—What Are the Roles of Genetic Factors in Lung Cancer Pathogenesis? In: Kaneko T, editor. Clinical Relevance of Genetic Factors in Pulmonary Disease. Springer; 2018 [Diakses 2019 Dec 8]. p. 193–206.
- 15.	Barros-Filho MC, Guiser F, Rock LD, Becker-Santos DD, Sage AP, Marshall EA, et al. Tumour Suppressor Genes with Oncogenic Roles in Lung Cancer. In: Lemamy GJ (ed). Genes and Cancer. IntechOpen; 2019. p. 1–17.
- 16.	Hu W, Fan C, Jiang P, Ma Z, Yan X, Di S, et al. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer. Oncotarget. 2016;7(1).
- 17.	Li S, Huang SM, Lim J, Kim J. Expression profiling of the differentiation related protein N‐myc downstream regulated gene 2 in normal human tissues. Basic and Applied Pathology. 2008;1: 77-82.
- 18.	Faraji SN, Mojtahedi Z, Ghalamfarsa Gh, Takhshid MA. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro. Iran J Basic Med Sci. 2015;18:773-779.
- 19.	Kim A, Kim MJ, Yang Y, Kim JW, et al. Suppression of NF-kB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis. 2009; 30(6): 927-936.
- 20.	American Joint Committee on Cancer. Lung. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/essential/full-58646>

{% include adsense2.html %}

### Published
2021-08-01

### How To Cite
PRASTISIA, Yulian; MANGKULIGUNA, Ghea; TOBIAN, Nikolaus.  N-MYC DOWNSTREAM-REGULATED GENE 2 (NDRG2): INOVASI PENANDA TUMOR DIAGNOSTIK DAN PROGNOSTIK TERBARU UNTUK KANKER PARU.Essential: Essence of Scientific Medical Journal, [S.l.], v. 19, n. 1, p. 34-38, aug. 2021. ISSN 2655-6472. Available at: <https://jurnal.harianregional.com/essential/id-58646>. Date accessed: {{ site.time | date: "%d %b. %Y" }}.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol 19 No 1 (2021): Volume 19 No. 1 (Januari - Juni 2021) Essential: Essence of Scientific Medical Journal

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
